Keitaro Doi
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
- Co-authors
- Manabu Muto (4 shared papers)Shigemi Matsumoto (4 shared papers)Tomoki Saito (1 shared paper)Kōichi Inoue (1 shared paper)Kiichiro Baba (1 shared paper)Ryosuke Nagatomo (1 shared paper)Motoo Nomura (2 shared papers)Takehiko Tsumura (3 shared papers)
- Journals
- Cancers (1 paper)JAMA Network Open (1 paper)Journal of Clinical Medicine (1 paper)Medical Oncology (1 paper)BMC Cancer (1 paper)
- Partner nations
- Japan
In The Last Decade
Keitaro Doi
7 papers receiving 316 citations
Keitaro Doi's Hit Papers
Peers
Comparison fields: 5 of 44
- Biological Psychiatry 33
- Oncology 143
- Molecular Biology 220
- Infectious Diseases 42
- Biotechnology 19
Countries citing papers authored by Keitaro Doi
This map shows the geographic impact of Keitaro Doi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keitaro Doi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keitaro Doi more than expected).
Fields of papers citing papers by Keitaro Doi
This network shows the impact of papers produced by Keitaro Doi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keitaro Doi. The network helps show where Keitaro Doi may publish in the future.
Co-authors
The 25 scholars most cited alongside Keitaro Doi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors Hit paper breakdown → | 2020 | 298 |
| 2 | 2022 | 7 | |
| 3 | 2022 | 5 | |
| 4 | 2020 | 4 | |
| 5 | 2022 | 2 | |
| 6 | 2020 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2019 | 0 |
About Keitaro Doi
Keitaro Doi is a scholar working on Oncology, Surgery, Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 8 papers that have together received 319 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (3 papers), Cancer Genomics and Diagnostics (2 papers), Gut microbiota and health (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Central Venous Catheters and Hemodialysis (1 paper), Epigenetics and DNA Methylation (1 paper), Gastric Cancer Management and Outcomes (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Biological Psychiatry (33 citations), Oncology (143 citations), Molecular Biology (220 citations), Infectious Diseases (42 citations) and Biotechnology (19 citations). Keitaro Doi has collaborated with scholars based in Japan. Frequent co-authors include Manabu Muto, Shigemi Matsumoto, Tomoki Saito, Kōichi Inoue, Kiichiro Baba, Ryosuke Nagatomo, Motoo Nomura, Takehiko Tsumura, Hiroyuki Marusawa and Hisateru Yasui. Their work appears in journals such as Cancers, JAMA Network Open, Journal of Clinical Medicine, Medical Oncology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.